185 related articles for article (PubMed ID: 22898210)
1. PTK7: a new biomarker for immunophenotypic characterization of maturing T cells and T cell acute lymphoblastic leukemia.
Jiang G; Zhang M; Yue B; Yang M; Carter C; Al-Quran SZ; Li B; Li Y
Leuk Res; 2012 Nov; 36(11):1347-53. PubMed ID: 22898210
[TBL] [Abstract][Full Text] [Related]
2. PTK7 is a molecular marker for metastasis, TNM stage, and prognosis in oral tongue squamous cell carcinoma.
Dong Y; Chen X; Li H; Ni Y; Han W; Wang J
Pol J Pathol; 2017; 68(1):49-54. PubMed ID: 28547980
[TBL] [Abstract][Full Text] [Related]
3. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7-positive tumours.
Liu M; Ma W; Li Q; Zhao D; Shao X; Huang Q; Hao L; Lin Y
Cell Prolif; 2019 Jan; 52(1):e12511. PubMed ID: 30311693
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
[TBL] [Abstract][Full Text] [Related]
6. Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection.
Roshal M; Fromm JR; Winter S; Dunsmore K; Wood BL
Cytometry B Clin Cytom; 2010 May; 78(3):139-46. PubMed ID: 20155852
[TBL] [Abstract][Full Text] [Related]
7. Detection of minimal residual disease in B lymphoblastic leukemia using viSNE.
DiGiuseppe JA; Tadmor MD; Pe'er D
Cytometry B Clin Cytom; 2015; 88(5):294-304. PubMed ID: 25974871
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions.
Cheng J; Klairmont MM; Choi JK
Pediatr Blood Cancer; 2019 Jan; 66(1):e27453. PubMed ID: 30255571
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.
Du W; Li J; Liu W; He Y; Yao J; Liu Y; Lin J; Zheng J
Tumour Biol; 2016 Mar; 37(3):3817-21. PubMed ID: 26474588
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the specific interaction between the DNA aptamer sgc8c and protein tyrosine kinase-7 receptors at the surface of T-cells by biosensing AFM.
Leitner M; Poturnayova A; Lamprecht C; Weich S; Snejdarkova M; Karpisova I; Hianik T; Ebner A
Anal Bioanal Chem; 2017 Apr; 409(11):2767-2776. PubMed ID: 28229174
[TBL] [Abstract][Full Text] [Related]
11. The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.
Prebet T; Lhoumeau AC; Arnoulet C; Aulas A; Marchetto S; Audebert S; Puppo F; Chabannon C; Sainty D; Santoni MJ; Sebbagh M; Summerour V; Huon Y; Shin WS; Lee ST; Esterni B; Vey N; Borg JP
Blood; 2010 Sep; 116(13):2315-23. PubMed ID: 20558616
[TBL] [Abstract][Full Text] [Related]
12. Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma.
DiGiuseppe JA; Wood BL
Cytometry B Clin Cytom; 2019 Jul; 96(4):256-265. PubMed ID: 31231940
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotyping of Acute Lymphoblastic Leukemia.
DiGiuseppe JA; Cardinali JL
Methods Mol Biol; 2019; 2032():297-310. PubMed ID: 31522425
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 maturation pattern in T-cells distinguishes thymic neoplasm/hyperplasia, T-lymphoblastic lymphoma, and reactive lymph nodes.
Ward N; Baqai J; Zehnpfennig A; Fine N; Huang J; Smith MD
Cytometry B Clin Cytom; 2018 May; 94(3):444-450. PubMed ID: 28718205
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of PTK7 in human malignancies.
Chen G; Qi S; Yang X; Chen W
Histol Histopathol; 2018 Apr; 33(4):379-388. PubMed ID: 28924970
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia.
Shabani M; Asgarian-Omran H; Jeddi-Tehrani M; Vossough P; Faranoush M; Sharifian RA; Toughe GR; Kordmahin M; Khoshnoodi J; Roohi A; Tavoosi N; Mellstedt H; Rabbani H; Shokri F
Tumour Biol; 2007; 28(6):318-26. PubMed ID: 18354269
[TBL] [Abstract][Full Text] [Related]
17. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
Dworzak MN; Fröschl G; Printz D; Zen LD; Gaipa G; Ratei R; Basso G; Biondi A; Ludwig WD; Gadner H
Leukemia; 2004 Apr; 18(4):703-8. PubMed ID: 14961034
[TBL] [Abstract][Full Text] [Related]
18. Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function.
Haines CJ; Giffon TD; Lu LS; Lu X; Tessier-Lavigne M; Ross DT; Lewis DB
J Exp Med; 2009 Feb; 206(2):275-85. PubMed ID: 19171767
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-MALAT1 regulates proliferation and apoptosis of acute lymphoblastic leukemia cells via miR-205-PTK7 pathway.
Song Y; Guo NH; Zheng JF
Pathol Int; 2020 Oct; 70(10):724-732. PubMed ID: 32754978
[TBL] [Abstract][Full Text] [Related]
20. Organization of the human PTK7 gene encoding a receptor protein tyrosine kinase-like molecule and alternative splicing of its mRNA.
Jung JW; Ji AR; Lee J; Kim UJ; Lee ST
Biochim Biophys Acta; 2002 Dec; 1579(2-3):153-63. PubMed ID: 12427550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
